0

Vasculitides Collection
 1-20 of 170 Articles
Original Research |  5 November 2013
The Association Between Dietary Patterns at Midlife and Health in Aging: An Observational Study
Cécilia Samieri, PhD; Qi Sun, MD, ScD; Mary K. Townsend, ScD; et al.
Ann Intern Med. 2013;159(9):584-591. doi:10.7326/0003-4819-159-9-201311050-00004
Original Research |  4 October 2011
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis
Lorenzo Dagna, MD; Fulvio Salvo, MD; Mirta Tiraboschi, MD; et al.
Ann Intern Med. 2011;155(7):425-433. doi:10.7326/0003-4819-155-7-201110040-00005
Articles |  19 May 2009
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis: A Randomized Trial
Kirsten de Groot, MD; Lorraine Harper, MD, PhD; David R.W. Jayne, MD, PhD; et al.
Ann Intern Med. 2009;150(10):670-680. doi:10.7326/0003-4819-150-10-200905190-00004
Articles |  6 November 2007
Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis
Javier D. Finkielman, MD; Peter A. Merkel, MD, MPH; Darrell Schroeder, MS; et al.
Ann Intern Med. 2007;147(9):611-619. doi:10.7326/0003-4819-147-9-200711060-00005
Articles |  1 May 2007
Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis: A Randomized Trial
Gary S. Hoffman, MD; Maria C. Cid, MD; Karen E. Rendt-Zagar, MD; et al.
Ann Intern Med. 2007;146(9):621-630. doi:10.7326/0003-4819-146-9-200705010-00004
Articles |  1 November 2005
Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic Antibody–Associated Small-Vessel Vasculitis
Susan L. Hogan, PhD, MPH; Ronald J. Falk, MD; Hyunsook Chin, MPH; et al.
Ann Intern Med. 2005;143(9):621-631. doi:10.7326/0003-4819-143-9-200511010-00005
Articles |  1 November 2005
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Régis Sablé-Fourtassou, MD; Pascal Cohen, MD; Alfred Mahr, MD; et al.
Ann Intern Med. 2005;143(9):632-638. doi:10.7326/0003-4819-143-9-200511010-00006
Editorials |  1 November 2005
Are There Different Forms of Life in the Antineutrophil Cytoplasmic Antibody Universe?
Gary S. Hoffman, MD, MS; Carol A. Langford, MD, MHS
Ann Intern Med. 2005;143(9):683-685. doi:10.7326/0003-4819-143-9-200511010-00012
Articles |  19 April 2005
Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study
Peter A. Merkel, MD, MPH; Grace H. Lo, MD; Janet T. Holbrook, PhD, MPH; et al.
Ann Intern Med. 2005;142(8):620-626. doi:10.7326/0003-4819-142-8-200505030-00011
Reviews |  1 March 2005
Meta-Analysis: Test Performance of Ultrasonography for Giant-Cell Arteritis
Fotini B. Karassa, MD; Miltiadis I. Matsagas, MD; Wolfgang A. Schmidt, MD; et al.
Ann Intern Med. 2005;142(5):359-369. doi:10.7326/0003-4819-142-5-200503010-00011
Reviews |  16 September 2003
Giant-Cell Arteritis and Polymyalgia Rheumatica
Cornelia M. Weyand, MD; Jörg J. Goronzy, MD
Ann Intern Med. 2003;139(6):505-515. doi:10.7326/0003-4819-139-6-200309160-00015
Articles |  20 August 2002
Is Duplex Ultrasonography Useful for the Diagnosis of Giant-Cell Arteritis?
Carlo Salvarani, MD; Mauro Silingardi, MD; Angelo Ghirarduzzi, MD; et al.
Ann Intern Med. 2002;137(4):232-238. doi:10.7326/0003-4819-137-4-200208200-00006
Articles |  16 January 2001
Combined Treatment of Giant-Cell Arteritis with Methotrexate and Prednisone: A Randomized, Double-Blind, Placebo-Controlled Trial
Juan A. Jover, MD, PhD; César Hernández-García, MD, PhD; Inmaculada C. Morado, MD; et al.
Ann Intern Med. 2001;134(2):106-114. doi:10.7326/0003-4819-134-2-200101160-00010
Brief Communications |  2 March 1999
Mycophenolate Mofetil for the Treatment of Takayasu Arteritis: Report of Three Cases
Erica Daina, MD; Arrigo Schieppati, MD; Giuseppe Remuzzi, MD
Ann Intern Med. 1999;130(5):422-426. doi:10.7326/0003-4819-130-5-199903020-00013
Articles |  1 September 1998
Limitations of the 1990 American College of Rheumatology Classification Criteria in the Diagnosis of Vasculitis
Jaya K. Rao, MD, MHS; Nancy B. Allen, MD; Theodore Pincus, MD
Ann Intern Med. 1998;129(5):345-352. doi:10.7326/0003-4819-129-5-199809010-00001
Brief Communications |  1 September 1998
Interferon-α Treatment of Four Patients with the Churg-Strauss Syndrome
Efstratios Tatsis, MD; Armin Schnabel, MD; Wolfgang L. Gross, MD
Ann Intern Med. 1998;129(5):370-374. doi:10.7326/0003-4819-129-5-199809010-00004
Reviews |  15 July 1998
Relapsing Polychondritis
David E. Trentham, MD; Christine H. Le, MBBS, FRACP
Ann Intern Med. 1998;129(2):114-122. doi:10.7326/0003-4819-129-2-199807150-00011
Articles |  15 March 1998
Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
Vedat Hamuryudan, MD; Cem Mat, MD; Sebahattin Saip, MD; et al.
Ann Intern Med. 1998;128(6):443-450. doi:10.7326/0003-4819-128-6-199803150-00004
Editorials |  15 March 1998
Behcet Disease and the Emergence of Thalidomide
George E. Ehrlich, MD
Ann Intern Med. 1998;128(6):494-495. doi:10.7326/0003-4819-128-6-199803150-00011
Brief Reports |  15 May 1996
Successful Treatment of Behcet Disease with Pentoxifylline
Kozo Yasui, MD; Kouichi Ohta, MD; Masakazu Kobayashi, MD; et al.
Ann Intern Med. 1996;124(10):891-893. doi:10.7326/0003-4819-124-10-199605150-00005
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)